Melanoma / Solid Tumor Cell Therapy Research Position

Melanoma / Solid Tumor Cell Therapy Research Position

HonorHealth Research Institute

Scottsdale, Arizona

As part of a non-profit healthcare system with nine hospitals and primary teaching affiliate for the new Arizona State University School of Medicine and Advanced Medical Engineering and Center for Translational Science, the Division of Cancer Research is seeking Board Certified Medical Oncologists with clinical research expertise / interest in

Melanoma and Solid Tumor Cellular Therapy to join a Cutaneous Oncology Program

Join the preeminent Phase 1 Oncology Drug Development Program in the Southwest US

HonorHealth Research Institute (HRI)

HRI is seeking a Board-Certified Oncologist to join the Melanoma and Solid tumor Cellular Therapy Program which sees patients with all types of advanced cutaneous malignancies for both standard of care and clinical trial treatments in collaboration with the HonorHealth Dermatology Residency Program .   The program has a special focus on uveal / ocular melanoma with multiple clinical trials and translational research programs focused on this rare tumor.  The Research Oncologist will partner with the Melanoma Medical Oncologist and will independently lead Phase 1 & 2 clinical trials .  The successful candidate will have the opportunity to lead early phase clinical trials and participate in novel cellular therapy and bispecific antibody trials.

Established in 2005 , the HonorHealth Research Institute (HRI) is part of a nine-hospital integrated healthcare system in the Scottsdale / Phoenix metro area.    The HRI Cancer Research Division is affiliated with HonorHealth Cancer Care, the largest community multi-specialty Cancer Care program in the region  delivers primary cancer care to approximately 1 / 3 of all newly diagnosed cancer patients in the Phoenix metropolitan area.

HonorHealth is the primary clinical  affiliate for the new Arizona State University School of Medicine and Advanced Medical  Engineering who will be accepting the first class of medical students in 2026; This creates an exciting opportunity to help build a unique  medical school.  As a dual degree program, the focus for the ASU SOMME will go beyond traditional course curriculum and will foster innovation through the use of artificial intelligence, data science, and other advanced technologies in healthcare.

HRIs new Center Translational Science   will use new techniques and disciplines rooted in the molecular (DNA) basis of disease, the new Center for Translational Science will build on the Research Institutes expertise in developing first-in-human clinical trials, immune-system therapies, cellular therapies, targeted therapies and others to develop treatments that attack diseases, while minimizing negative side effects that might compromise a patients health.  T he new center is seen as a worldwide bridge among scientists, researchers and physicians in their pursuit of new diagnostics and therapeutics to benefit patients.

As a part of the regions only locally owned, locally managed non-profit healthcare system with an expansive cancer care footprint, HRI is dedicated to offering patients thoughtful, compassionate care and access to novel treatments through innovative clinical research.    The focus of the Division of Cancer Research is on providing access to new and novel clinical trials for patients with relapsed and refractory cancer within the state of Arizona and across the United States.  Our collaborators include global biopharmaceutical, biotechnology, medical device, and clinical research organizations.

HonorHealth Research Institute impacts the value and quality of patient care by accelerating innovation, while seamlessly integrating the latest science, including :

• 215 Active Clinical Studies
• 48 New Clinical Studies Opened
• 371 Subjects Enrolled in Clinical Studies
• 118 Active Investigators and Physicians

HRI Clinical Research Oncologists benefit from being a part of a community-based research program which has access to additional resources with reduced administrative layers and generous philanthropic support .   Faculty have the opportunity to join the Arizona State University School of Medicine and Advanced Medical Engineering  program as adjunct faculty where they serve as preceptors and lecturers for clinical rotations and pre-clinical courses.

The successful candidate will engage with community hematology / oncology partners in the Phoenix metropolitan area supporting expansion of access to current bispecific antibody options for lymphoma and multiple myeloma with a focus on disease or therapeutic approaches.

Responsibilities :

Why Scottsdale?

To learn more about HRI Clinical Research Oncology positions, please submit your CV for consideration or contact the HonorHealth Physician Recruitment Partner :

Laura Hays

480-227-2995

Lhays@TrekPhysician.com